Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib versus placebo in severe uncontrolled asthma with eosinophilia
TCTR20161129004Phase 3Not yet recruiting
- Sponsor
- AB Science
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of masitinib in eosinophilic asthma (EA), sponsored by AB Science. Planned start Feb 2017; status: not yet recruiting.
02
Drugs
masitinib
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on TCTR20161129004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161129004.